Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Asp015k Hydrobromide
2. Asp-015k Hydrobromide
3. Peficitinib Hydrobromide [usan]
4. U55xhz5x6p
5. 1353219-05-2
6. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((anti-5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1)
7. Asp 015k Hydrobromide
8. Unii-u55xhz5x6p
9. Smyraf (tn)
10. Schembl9990237
11. Chembl3137329
12. Schembl14876111
13. Schembl14876113
14. Peficitinib Hydrobromide (jan/usan)
15. Peficitinib Hydrobromide [who-dd]
16. D10721
17. Q27290703
18. 1h-pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, Hydrobromide (1:1), Stereoisomer
19. 4-(((1r,2s,3s,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1h-pyrrolo(2,3-b)pyridine-5-carboxamide Monohydrobromide
Molecular Weight | 407.3 g/mol |
---|---|
Molecular Formula | C18H23BrN4O2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 406.10044 g/mol |
Monoisotopic Mass | 406.10044 g/mol |
Topological Polar Surface Area | 104 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 525 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Under the agreement, Menarini will develop, manufacture and commercialise orally administered Janus kinase (JAK) inhibitor Smyraf Tablets (generic name: peficitinib hydrobromide) in Taiwan for the treatment of rheumatoid arthritis.
Lead Product(s): Peficitinib Hydrobromide
Therapeutic Area: Immunology Brand Name: Smyraf
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Menarini
Deal Size: $5.9 million Upfront Cash: Undisclosed
Deal Type: Licensing Agreement September 12, 2023
Lead Product(s) : Peficitinib Hydrobromide
Therapeutic Area : Immunology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Menarini
Deal Size : $5.9 million
Deal Type : Licensing Agreement
Details : Under the agreement, Menarini will develop, manufacture and commercialise orally administered Janus kinase (JAK) inhibitor Smyraf Tablets (generic name: peficitinib hydrobromide) in Taiwan for the treatment of rheumatoid arthritis.
Product Name : Smyraf
Product Type : Small molecule
Upfront Cash : Undisclosed
September 12, 2023
Global Sales Information
Market Place
Reply
20 Jul 2022
ABOUT THIS PAGE
20
PharmaCompass offers a list of Peficitinib Hydrobromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Peficitinib Hydrobromide manufacturer or Peficitinib Hydrobromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Peficitinib Hydrobromide manufacturer or Peficitinib Hydrobromide supplier.
PharmaCompass also assists you with knowing the Peficitinib Hydrobromide API Price utilized in the formulation of products. Peficitinib Hydrobromide API Price is not always fixed or binding as the Peficitinib Hydrobromide Price is obtained through a variety of data sources. The Peficitinib Hydrobromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Peficitinib Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Peficitinib Hydrobromide, including repackagers and relabelers. The FDA regulates Peficitinib Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Peficitinib Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Peficitinib Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Peficitinib Hydrobromide supplier is an individual or a company that provides Peficitinib Hydrobromide active pharmaceutical ingredient (API) or Peficitinib Hydrobromide finished formulations upon request. The Peficitinib Hydrobromide suppliers may include Peficitinib Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Peficitinib Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Peficitinib Hydrobromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Peficitinib Hydrobromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Peficitinib Hydrobromide GMP manufacturer or Peficitinib Hydrobromide GMP API supplier for your needs.
A Peficitinib Hydrobromide CoA (Certificate of Analysis) is a formal document that attests to Peficitinib Hydrobromide's compliance with Peficitinib Hydrobromide specifications and serves as a tool for batch-level quality control.
Peficitinib Hydrobromide CoA mostly includes findings from lab analyses of a specific batch. For each Peficitinib Hydrobromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Peficitinib Hydrobromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Peficitinib Hydrobromide EP), Peficitinib Hydrobromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Peficitinib Hydrobromide USP).